| Application no. and date | 98960732.0 (espacenet) (Federated) (European Patent Register), 19981204 | | Patent/reg. no. and date | DK/EP 1039895, 20020605 | | Publication date | 20001004 | | Priority no. and date | US 994903, 19971219 | | EP pub. no. and date |
EP 1039895 20001004 | | Effective date | | | Applicant/owner | ALCON LABORATORIES, INC., 6201 South Freeway
Fort Worth
Texas 76134-2099, US | | Applicant ref. no. | P200200824 | | Inventor | YANNI, John, M., 2821 Donnybrook Drive
Burleson, TX 76028, US,
HELLBERG, Mark, R., 5211 Overridge Drive
Arlington, TX 76017, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/165, A61K 31/19, A61K 31/195, A61P 27/06, A61K 31/215 | | Title | Anvendelse af 3-benzoylphenyleddikesyrer, estere eller amider til behandling af GLC1A-glaukom | | Int. application no. | PCT/US98/25744 | | Int. publication no. | WO99032104 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
